Evidence map›Paper›PMID 35461909›Full record

SynthesisThe Journal of infection2022

Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.

Guangyu Ao, Toni Li, Yushu Wang, Carolyn Tran, Xin Qi

Abstract readLetterMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. SARS-CoV-2 Omicron BA.5: Riding the seventh wave in Central Canada.Influenza and other respiratory viruses · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guangyu AoDepartment of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Toni LiSchool of Medicine, Queen's University, Kingston, Canada.
Yushu WangChengdu West China Clinical Research Center, Chengdu, Sichuan, China.
Carolyn TranSchulich School of Medicine & Dentistry, Western University, London, Canada.
Xin QiDepartment of Neurology, the Affiliated Hospital of Southwest Jiaotong University & the Third People's Hospital of Chengdu, Chengdu, Sichuan, China. Electronic address: qixinchengdu@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingHumansSARS-CoV-2Antibodies, Monoclonal, HumanizedAntibodies, NeutralizingsotrovimabCOVID-19MortalitySARS-CoV-2Sotrovimab

Identifiers

PMID35461909
PMCPMC9021041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.